ACHL - Achilles Therapeutics plc (ACHL) CEO Iraj Ali on SITC & Corporate Update Call (Transcript)
Achilles Therapeutics plc (ACHL) SITC & Corporate Update Call November 12, 2021 08:30 AM ET Company Participants Lee Stern - VP, IR & External Communications Iraj Ali - CEO Karl Peggs - CMO Sergio Quezada - CSO Samra Turajlic - Chief Investigator, THETIS Conference Call Participants Joe Catanzaro - Piper Sandler Tazeen Ahmad - Bank of America Ingrid Gafanhao - Kempen Presentation Lee Stern We are glad you joined us for our review of today's SITC presentations and a brief corporate update. Prior to this call we issued a press release and posted a slide presentation that can be found on our website at www.achillestx.com. We will refer to this during our prepared remarks. On today's call we have the pleasure of being joined by Dr. Samra Turajlic of the Royal Marsden's NHS Foundation Trust. Dr. Turajlic is the Chief Investigator of our THETIS clinical trial. In addition from Achilles,
For further details see:
Achilles Therapeutics plc (ACHL) CEO Iraj Ali on SITC & Corporate Update Call (Transcript)